Sino-Agri Leading Biosciences Co.,Ltd (SHSE:603970) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Sino-Agri Leading Biosciences Co.,Ltd (SHSE:603970) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
With its stock down 25% over the past month, it is easy to disregard Sino-Agri Leading BiosciencesLtd (SHSE:603970). However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes, the company is worth looking at. In this article, we decided to focus on Sino-Agri Leading BiosciencesLtd's ROE.
隨着過去一個月股價下跌25%,人們很容易忽視中國農業領先生物科技股份有限公司(SHSE:603970)。然而,對其健康的財務狀況進行更仔細的觀察可能會讓你再次考慮。鑑於基本面通常推動長期市場結果,因此值得關注該公司。在本文中,我們決定聚焦於中國農業領先生物科技股份有限公司的ROE。
Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. Simply put, it is used to assess the profitability of a company in relation to its equity capital.
股東權益回報率(ROE)是測試公司如何有效地增加其價值並管理投資者資金的指標。簡而言之,它用於評估公司相對於股本資本的盈利能力。
How Is ROE Calculated?
淨資產收益率怎麼計算?
The formula for ROE is:
roe的公式是:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
淨資產收益率 = 淨利潤(從持續經營中獲得)÷ 股東權益
So, based on the above formula, the ROE for Sino-Agri Leading BiosciencesLtd is:
因此,根據以上公式,中國農業領先生物科技股份有限公司的ROE爲:
15% = CN¥251m ÷ CN¥1.7b (Based on the trailing twelve months to March 2024).
15%= CN¥25100萬 ÷ CN¥17億(基於過去12個月截至2024年3月)。
The 'return' is the income the business earned over the last year. That means that for every CN¥1 worth of shareholders' equity, the company generated CN¥0.15 in profit.
"回報"是企業上一年度賺取的收入。這意味着,對於每個股東權益價值爲CN¥1的公司,在利潤方面產生CN¥0.15的效益。
What Is The Relationship Between ROE And Earnings Growth?
ROE與盈利增長之間的關係是什麼?
Thus far, we have learned that ROE measures how efficiently a company is generating its profits. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company's earnings growth potential. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics.
到目前爲止,我們已經了解到roe衡量公司生成利潤的效率。根據公司再投資或“保留”的利潤比例及其有效性,我們能夠評估公司的收益增長潛力。在其他一切保持不變的情況下,roe和利潤保留率越高,公司的增長率就越高,相比於那些不一定擁有這些特性的公司。
Sino-Agri Leading BiosciencesLtd's Earnings Growth And 15% ROE
Sino-Agri Leading BiosciencesLtd的盈利增長和15%的roe。
To begin with, Sino-Agri Leading BiosciencesLtd seems to have a respectable ROE. On comparing with the average industry ROE of 6.4% the company's ROE looks pretty remarkable. This probably laid the ground for Sino-Agri Leading BiosciencesLtd's moderate 16% net income growth seen over the past five years.
首先,Sino-Agri Leading BiosciencesLtd的roe看起來相當可觀。與行業平均的6.4%的roe相比,該公司的roe看起來非常出色。這可能爲Sino-Agri Leading BiosciencesLtd過去五年中適度的16%的淨收入增長奠定了基礎。
Next, on comparing with the industry net income growth, we found that Sino-Agri Leading BiosciencesLtd's growth is quite high when compared to the industry average growth of 7.9% in the same period, which is great to see.
接下來,與行業淨收入增長相比,我們發現Sino-Agri Leading BiosciencesLtd的增長相當高,相比於同期行業平均增長的7.9%,這是非常好的。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240712/0-a0040bbf1eecb72e365bf4aa457f5fd3-0-019d2beea76781397a0a35ed1fc66c12.png/big)
Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. This then helps them determine if the stock is placed for a bright or bleak future. One good indicator of expected earnings growth is the P/E ratio which determines the price the market is willing to pay for a stock based on its earnings prospects. So, you may want to check if Sino-Agri Leading BiosciencesLtd is trading on a high P/E or a low P/E, relative to its industry.
盈利增長是估值股票時需要考慮的重要指標。投資者應該試圖確定預期的盈利增長或下降,無論哪種情況,是否已經反映在股價中。這可以幫助他們判斷股票是否面臨明亮或暗淡的未來。一個好的預期盈利增長指標是P/E比率,它確定市場願意支付多少錢購買一隻股票,基於它的盈利前景。所以,你可能想檢查一下Sino-Agri Leading BiosciencesLtd是在高P/E還是低P/E交易,相對於該行業來說。
Is Sino-Agri Leading BiosciencesLtd Making Efficient Use Of Its Profits?
中國農業領先生物科技股份有限公司是否高效利用其利潤?
Sino-Agri Leading BiosciencesLtd has a three-year median payout ratio of 42%, which implies that it retains the remaining 58% of its profits. This suggests that its dividend is well covered, and given the decent growth seen by the company, it looks like management is reinvesting its earnings efficiently.
Sino-Agri Leading BiosciencesLtd的三年中位數派息比率爲42%,這意味着它保留了其剩餘58%的利潤。這表明它的股息是有很好的保障的,並且鑑於公司的良好增長表現,看起來管理層正在高效地重新投資其盈利。
Moreover, Sino-Agri Leading BiosciencesLtd is determined to keep sharing its profits with shareholders which we infer from its long history of six years of paying a dividend.
此外,我們從其長達六年的分紅歷史中推斷,中國農業領先生物科技股份有限公司決心繼續向股東分享利潤。
Conclusion
結論
Overall, we are quite pleased with Sino-Agri Leading BiosciencesLtd's performance. Specifically, we like that the company is reinvesting a huge chunk of its profits at a high rate of return. This of course has caused the company to see substantial growth in its earnings. Having said that, looking at the current analyst estimates, we found that the company's earnings are expected to gain momentum. To know more about the latest analysts predictions for the company, check out this visualization of analyst forecasts for the company.
總體而言,我們對Sino-Agri Leading BiosciencesLtd的表現感到非常滿意。特別的,我們喜歡這家公司以高回報率重新投資其龐大的利潤份額。當然,這導致公司收到了可觀的盈利增長。話雖如此,通過查看當前的分析師預測,我們發現該公司的盈利預計將加速增長。要了解更多有關該公司的最新分析師預測,請查看該公司的分析師預測可視化。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。